Drosten M, Hilken G, Rödicker F, Boeckmann M, Theseling CC, Miše N, Cranston AN, Frilling A, Ponder BA, Pützer BM.
Loss of neoplastic phenotype by specific inhibition of RET oncogene signalling in a transgenic model of primary medullary thyroid carcinoma.
Mol Ther. 2004; 9: S361-S361 943 Suppl. 1.
Previous Post
Discovery of targeting peptides for selective therapy of medullary thyroid carcinoma.
Next Post
Adenoviraler Gentransfer von p53 hemmt die Proliferation humaner Tenonfibroblasten.